Comparison of beta-Propiolactone and Formalin Inactivation on Antigenicity and Immune Response of West Nile Virus

被引:15
作者
Chowdhury, Pritom [1 ,2 ]
Topno, Rashmee [1 ]
Khan, Siraj A. [1 ]
Mahanta, Jagadish [1 ]
机构
[1] ICMR, Reg Med Res Ctr, Entomol & Filariasis Div, Arbovirol Grp,Northeast Reg, Post Box 105, Dibrugarh 786001, Assam, India
[2] TRA, Tocklai Tea Res Inst, Dept Biotechnol, Jorhat 785008, Assam, India
关键词
D O I
10.1155/2015/616898
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
West Nile Virus (WNV) is a pathogenic arbovirus that belongs to genus Flavivirus under family Flaviviridae. Till now there are no approved vaccines against WNV for human use. In this study, the effect of two alkylating agents, formaldehyde and beta-PL, generally used for inactivated vaccine preparation, was assessed on the basis of antigenic and immunogenic potential of the inactivated WNV. Lineage 5 WNV isolates were inactivated by both formalin and beta-PL treatments. Inactivation was confirmed by repeated passage in BHK-21 cell line and infant mice. Viruses inactivated by both the treatments showed higher antigenicity. Immune response in mice model showed serum anti-WNV antibody titre was moderately higher in formalin inactivated antigen compared to beta-PL inactivated antigen. However, no significant differences were observed in neutralization antibody titre. In conclusion, we can state that both formaldehyde and beta-PL inactivation processes were found to be equally efficient for inactivation of WNV. However, they need to be compared with other inactivating agents along with study on cell mediated immune response.
引用
收藏
页数:5
相关论文
共 34 条
[1]   Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum [J].
Andrighetti-Fröhner, CR ;
Antonio, RV ;
Creczynski-Pasa, TB ;
Barardi, CRM ;
Simoes, CMO .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2003, 98 (06) :843-848
[2]  
Banker D., 1952, INDIAN J MED SCI, V6, P733
[3]   DEVELOPMENTS IN FOOT-AND-MOUTH-DISEASE VACCINES [J].
BARTELING, SJ ;
VREESWIJK, J .
VACCINE, 1991, 9 (02) :75-88
[4]   Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults [J].
Biedenbender, Rex ;
Bevilacqua, Joan ;
Gregg, Anne M. ;
Watson, Mike ;
Dayan, Gustavo .
JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (01) :75-84
[5]   Detection of West Nile virus sequences in cerebrospinal fluid [J].
Briese, T ;
Glass, WG ;
Lipkin, WI .
LANCET, 2000, 355 (9215) :1614-1615
[6]  
BROWN F, 1993, DEV BIOL STAND, V81, P103
[7]   PRINCIPLES OF SELECTIVE INACTIVATION OF VIRAL GENOME .7. SOME PECULIARITIES IN DETERMINATION OF VIRAL SUSPENSION INFECTIVITY DURING INACTIVATION BY CHEMICAL-AGENTS [J].
BUDOWSKY, EI ;
FRIEDMAN, EA ;
ZHELEZNOVA, NV .
VACCINE, 1991, 9 (07) :473-476
[8]   West Nile virus [J].
Campbell, GL ;
Marfin, AA ;
Lanciotti, RS ;
Gubler, DJ .
LANCET INFECTIOUS DISEASES, 2002, 2 (09) :519-529
[9]   Immunogenic potential and protective efficacy of formalin inactivated circulating Indian strain of West Nile virus [J].
Chowdhury, Pritom ;
Khan, Siraj Ahmed ;
Topno, Rashmee ;
Dutta, Prafulla ;
Yadav, R. N. S. ;
Mahanta, Jagadish .
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2014, 7 (12) :946-951
[10]   Characterization of West Nile virus (WNV) isolates from Assam, India: Insights into the circulating WNV in northeastern India [J].
Chowdhury, Pritom ;
Khan, Siraj Ahmed ;
Dutta, Prafulla ;
Topno, Rashmee ;
Mahanta, Jagadish .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2014, 37 (01) :39-47